Pharmacogenomics in gastrointestinal disorders.
Genomic techniques offer new approaches to the investigation of the aetiology and pathophysiology of intestinal disorders. An important field that is relevant to treatment is the pharmacogenetic investigation of gene variations that may predict response to certain drugs in order to target these drugs more precisely. For the surgeon the perioperative situation will be here of great interest. To date only about 8000 of the estimated 30,000-50,000 human genes have been characterised, so the use of techniques for global analysis of gene expression may allow the identification of new pathways or molecules. In can be anticipated that genomic methods will profoundly influence the treatment of gastrointestinal disorders and will lead to new insights into both aetiology and pathophysiology of chronic intestinal inflammation.
Schreiber
Stefan
S
From the 1st Department of Medicine, Christian-Albrechts-University, Kiel, Germany. s.schreiber@mucosa.de
Costello
Christine M
CM
D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000503:physiopathology*; D015723:Gene Library; D014644:Genetic Variation; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000235:genetics / Q000503:physiopathology; D020411:Oligonucleotide Array Sequence Analysis; D010597:Pharmacogenetics; D050800:STAT6 Transcription Factor / Q000378:metabolism
D050800:STAT6 Transcription Factor; C494101:STAT6 protein, human